Outrage grows as CDC reportedly poised to fund “unethical” vaccine trial

Photo credit: Zoe Graham via Unsplash. Article by Beth Mole. Ars Technica – October 9, 2026.

Outrage has erupted among health experts over news that the Centers for Disease Control and Prevention is still eager to fund a widely condemned vaccine trial that would expose newborns in Guinea-Bissau to hepatitis B, putting them at high risk of a lifelong infection, which can lead to liver cirrhosis, liver cancer, and premature death. The trial was suspended in January after its unethical design came to light and drew international outcry. Although the trial is still halted, staff of the CDC director’s office told the agency’s budget office in late September to set aside $1.6 million to fund the trial, according to a report by Rolling Stone. […]

Click here to view the original article at www.arstechnica.com

Related articles:

Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau – The Guardian

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau – EIN News

CDC Is Moving Forward With a Previously Shelved Controversial Hepatitis B Vaccine Study – Rolling Stone